Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1996 1
1998 1
1999 5
2000 3
2001 2
2002 1
2004 2
2006 3
2007 2
2008 1
2009 2
2010 3
2013 1
2014 1
2015 1
2016 1
2019 2
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcome and prognostic factors in PCNSL.
Niparuck P, Boonsakan P, Sutthippingkiat T, Pukiat S, Chantrathammachart P, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Atichartakarn V. Niparuck P, et al. Among authors: ungkanont a. Diagn Pathol. 2019 Jun 13;14(1):56. doi: 10.1186/s13000-019-0833-1. Diagn Pathol. 2019. PMID: 31189479 Free PMC article.
Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study.
Srikajornlarp S, Amnueypol M, Vathesatogkit P, Numthavaj P, Ungkanont A, Likittanasombat K, Pattanaprateep O, Angchaisuksiri P, Boonyawat K. Srikajornlarp S, et al. Among authors: ungkanont a. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221130058. doi: 10.1177/10760296221130058. Clin Appl Thromb Hemost. 2022. PMID: 36198021 Free PMC article.
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification.
Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S. Anurathapan U, et al. Among authors: ungkanont a. Biol Blood Marrow Transplant. 2014 Dec;20(12):2066-71. doi: 10.1016/j.bbmt.2014.07.016. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064743 Free PMC article.
Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL.
Rungwittayatiwat S, Boonsakan P, Chantrathammachart P, Puavilai T, Pukiat S, Phusanti S, Boonyawat K, Wacharapornin P, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Niparuck P. Rungwittayatiwat S, et al. Among authors: ungkanont a. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021063. doi: 10.4084/MJHID.2021.063. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804437 Free PMC article.
Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMT.
Iida M, Liu K, Huang XJ, Depei W, Kuwatsuka Y, Moon JH, Dodds A, Wilcox L, Ko BS, Hamidieh AA, Ho KW, Ungkanont A, Ho A, Farzana T, Sim J, Man HV, Akter M, Abeysinghe P, Bravo MR, Gyi AA, Poudyal BS, Batshkh K, Srivastava A, Okamoto S, Atsuta Y; Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT). Iida M, et al. Among authors: ungkanont a. Blood Cell Ther. 2022 Jul 8;5(4):87-98. doi: 10.31547/bct-2022-002. eCollection 2022 Nov 25. Blood Cell Ther. 2022. PMID: 36713681 Free PMC article.
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia.
Niparuck P, Limsuwanachot N, Pukiat S, Chantrathammachart P, Rerkamnuaychoke B, Magmuang S, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S. Niparuck P, et al. Among authors: ungkanont a. Exp Hematol Oncol. 2019 Jan 30;8:3. doi: 10.1186/s40164-019-0127-z. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 30729065 Free PMC article.
The 2016 APBMT Activity Survey Report: Trends in haploidentical and cord blood transplantation in the Asia-Pacific region.
Iida M, Dodds A, Akter M, Srivastava A, Moon JH, Dung PC, Bravo MR, Gyi AA, Jayathilake D, Liu K, Ko BS, Hamidieh A, Ho KW, Ho A, Ungkanont A, Farzana T, Sim J, Poudyal B, Batshkh K, Okamoto S, Atsuta Y; Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT). Iida M, et al. Among authors: ungkanont a. Blood Cell Ther. 2021 Jan 29;4(2):20-28. doi: 10.31547/bct-2020-013. eCollection 2021 May 25. Blood Cell Ther. 2021. PMID: 36712901 Free PMC article.
Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
Anurathapan U, Hongeng S, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Iamsirirak P, Surapolchai P, Satayasai W, Sirireung S, Sruamsiri R, Wahidiyat PA, Ungkanont A, Issaragrisil S, Andersson BS. Anurathapan U, et al. Among authors: ungkanont a. Bone Marrow Transplant. 2016 Jun;51(6):813-8. doi: 10.1038/bmt.2016.7. Epub 2016 Feb 15. Bone Marrow Transplant. 2016. PMID: 26878659 Free PMC article.
Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control.
Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S. Anurathapan U, et al. Among authors: ungkanont a. Biol Blood Marrow Transplant. 2013 Aug;19(8):1259-62. doi: 10.1016/j.bbmt.2013.04.023. Epub 2013 May 3. Biol Blood Marrow Transplant. 2013. PMID: 23648235 Free PMC article. Clinical Trial.
38 results